IOVA Iovance Biotherapeutics, Inc.
$3.55
▼ 13.20%
41
Value
25
P/E-4.20
8
P/B2.06
47
P/S4.44
49
EV/EBITDA-3.44
5
Growth
65
Revenue Growth60.6%
100
EPS Growth14.8%
44
FCF Growth7.6%
45
Momentum
68
12-Month Return14.5%
58
3-Month Return50.4%
100
1-Month Return2.3%
57
RSI (14)41.71
50
50/200 MABullish
75
Profitability
22
ROE-50.2%
42
ROA-38.2%
0
Gross Margin114.5%
88
Operating Margin-127.2%
0
Net Margin-123.9%
0
FCF Yield-24.0%
0
Risk
25
Beta0.69
55
60-Day Volatility103.4%
0
QScore Analysis